Brainify.AI Company

AI/ML EEG biomarker platform for novel treatment development for depression in women, which increases the likelihood of new drug approval.

Funding Status: Seed
Headquarters: New York, New York, United States
Total Funding: 1600000
Last Funding Date: 2023-01-10
Founded Date: 2021-02-27
Technology: ['BioTech & HealthTech']
Industry: NeuroTech
Last Funding Type: Pre-Seed
Investor Type:
Employee Number: 11-50